Improving people’s quality of life
through innovative,
sustainable and effective pain relief
Innovation in pain relief

Breaking news

An illustration of a brain

What is chronic pain?

Pain is a negative feeling associated with damage to the body’s tissues and it is crucial to survival. Putting a hand on a very hot object “feels bad” and that negative feeling rapidly teaches even very young children not to do that again. This sort of acute pain that resolves when the damage stops makes perfect evolutionary sense.

Read more

pain therapy market

Treatment of neuropathic pain is still a clearly unmet medical need. There are no pain medicines which have universal efficacy and most partially effective drugs have unwanted morphine-like side effects.

Read more
A woman heaving a headache

HOW OUR NETWORK WORKS

PN6047
Chemnotia
PharminVivo
IP Station
Xenogesis
Trans-
pharmation
Cerep
Recipharm
Biosergan
SB Drug
Discovery
Renasci
University
of Nottingham
Liverpool
John Moores
University
University
of Pecs
University
of Mannerheim
University
of Reading
University
of Bristol
University
of Zürich
University
of Bath
Academic institutions
Contract Research Organisations

more news

View all
September 20, 2022

Good press in SvD

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

Read more
September 5, 2022

OP Team steps up

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

Read more
August 19, 2022

Phase I study initiated

We are pleased to inform that during the summer, the application to start

Read more
June 3, 2022

67 MSEK in new Founding

We are pleased to announce that we have raised 67 MSEK in a new share issue led by Sciety.

Read more

By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Awesome 👌